Tag Archives: Jill Anderson

KPAX002 as a treatment for ME/CFS – disappointing trial results

Posted on 04/17/2018 by wames

  Research abstract: KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a prospective, randomized trial, by Jose G Montoya, Jill N Anderson, Danya L Adolphs, Lucinda Bateman, Nancy Klimas, Susan M Levine, Donn W Garvert, Jon D Kaiser … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on KPAX002 as a treatment for ME/CFS – disappointing trial results

Researchers identify biomarkers associated with CFS severity

Posted on 08/02/2017 by wames

Stanford Medicine News Center press release, by Bruce Goldman, 31 July 2017: Researchers identify biomarkers associated with chronic fatigue syndrome severity Stanford investigators used high-throughput analysis to link inflammation to chronic fatigue syndrome, a difficult-to-diagnose disease with no known cure. … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Researchers identify biomarkers associated with CFS severity

Cytokine signature associated with disease severity in CFS patients

Posted on 08/02/2017 by wames

Cytokine signature associated with disease severity in chronic fatigue syndrome patients, by Jose G. Montoyaa, Tyson H. Holmes, Jill N. Anderson, Holden T. Maecker, Yael Rosenberg-Hasson, Ian J. Valencia, Lily Chu, Jarred W. Younger, Cristina M. Tato, and Mark M. … Continue reading →

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Cytokine signature associated with disease severity in CFS patients